drug metabolism Latest News

LabLogic Systems will launch Version 6 of its Debra LIMS for drug metabolism studies at the American Association of Pharmaceutical Scientists 2011 Annual Meeting and Exposition in Washington DC from 23 to 27 October.

Experts from LabLogic Systems will be on hand at the Society of Toxicology meeting (Washington DC 6-10 March, Booth 721) to explain the advantages of Debra, the LIMS that has set the standards for drug metabolism and ADME for almost two decades.

The latest comments on LabLogic Systems have come from Jonathan Attwood of AstraZeneca R & D in Charnwood, UK.

Greater flexibility in reporting data and additional features requested by users predominate in the new 5.7.7 release of Debra, LabLogic Systems’ market-leading LIMS for ADME studies.